Reuters -- Boston Scientific Corp (BSX.N) is indefinitely suspending all sales of its implantable cardioverter defibrillator devices as a result of a documentation error in its regulatory filings, an analyst at Bernstein Research said on Monday.
Reuters -- Boston Scientific Corp (BSX.N) is indefinitely suspending all sales of its implantable cardioverter defibrillator devices as a result of a documentation error in its regulatory filings, an analyst at Bernstein Research said on Monday.
